Transgenic Group Inc.
Notice Regarding Transfer of Fixed Assets (Kobe Research Institute) and Recording of Special Gain
Transferring fixed assets of the Kobe Research Institute and planning to record a gain on sale of fixed assets as a special gain. The transferee is not disclosed. Schedule: Board resolution date 2026-11-04, contract signing date 2026-11-09, handover date 2026-12-01. The special gain is expected to be recorded in Q3 of the fiscal year ending March 2027, while the impact on earnings forecasts remains under review.
Key Figures
- Transfer price: 1,266 million yen (transferee not disclosed)
- Book value: 912 million yen (as of September 30, 2026)
- Gain on transfer: 310 million yen
AI要約
Summary of the News
Transgenic Group Inc. will transfer fixed assets of the Kobe Research Institute and plans to record the resulting gain on sale as a special gain. This transaction is part of business function reallocation associated with the closure of the Kobe Research Institute and aims to improve capital efficiency. The transfer price was assessed for reasonableness based on a third-party appraisal. Schedule: Board resolution date 2026-11-04, contract signing date 2026-11-09, handover date 2026-12-01.
Outlook and Impact
The special gain is expected to be recorded in the consolidated accounting period for Q3 of the fiscal year ending March 2027. However, this special gain has not been incorporated into the full-year consolidated earnings forecast announced in May 2026, and the determination of its impact is under review. Any matters that should be disclosed in the future will be announced promptly.
Transgenic Group Inc.
Company overview · Stock price · Financial data · All IR
